Lin Lu
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
Papers in
-
- Cardiovascular Function and Risk Factors 11
- Cardiac Fibrosis and Remodeling 10
-
- Peroxisome Proliferator-Activated Receptors 5
- Co-authors
- Ruiyan Zhang (96 shared papers)Wei Feng Shen (73 shared papers)Qiujing Chen (62 shared papers)Xiao Qun Wang (35 shared papers)Ke Yang (23 shared papers)Ying Shen (45 shared papers)Jian Hu (29 shared papers)Weifeng Shen (29 shared papers)
- Journals
- Cardiovascular Diabetology (20 papers)PLoS ONE (11 papers)Atherosclerosis (9 papers)Journal of the American Heart Association (9 papers)International Journal of Cardiology (8 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Lin Lu
184 papers receiving 5.0k citations
Lin Lu's Hit Papers
Peers
Comparison fields: 5 of 140
- Clinical Biochemistry 500
- Cardiology and Cardiovascular Medicine 898
- Nephrology 263
- Cancer Research 445
- Endocrinology, Diabetes and Metabolism 495
Countries citing papers authored by Lin Lu
This map shows the geographic impact of Lin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Lu more than expected).
Fields of papers citing papers by Lin Lu
This network shows the impact of papers produced by Lin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Lu. The network helps show where Lin Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 193 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NCycDB: a curated integrative database for fast and accurate metagenomic profiling of nitrogen cycling genes Hit paper breakdown → | 2018 | 310 |
| 2 | Dectin-1 Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration Hit paper breakdown → | 2019 | 222 |
| 3 | 2011 | 218 | |
| 4 | 2008 | 116 | |
| 5 | 2015 | 110 | |
| 6 | 2020 | 103 | |
| 7 | 2016 | 91 | |
| 8 | 2014 | 76 | |
| 9 | 2011 | 73 | |
| 10 | 2017 | 72 | |
| 11 | 2006 | 71 | |
| 12 | 2010 | 65 | |
| 13 | Orphan Nuclear Receptor NR4A3 Promotes Vascular Calcification via Histone Lactylation Hit paper breakdown → | 2024 | 64 |
| 14 | 2015 | 64 | |
| 15 | 2014 | 63 | |
| 16 | The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. | 2015 | 62 |
| 17 | 2011 | 59 | |
| 18 | 2018 | 59 | |
| 19 | 2009 | 58 | |
| 20 | 2010 | 57 |
About Lin Lu
Lin Lu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Surgery, Immunology and Clinical Biochemistry, having authored 193 papers that have together received 5.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (14 papers), Cardiovascular Function and Risk Factors (11 papers), Cardiac Fibrosis and Remodeling (10 papers), Coronary Interventions and Diagnostics (8 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers), Atherosclerosis and Cardiovascular Diseases (7 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Protease and Inhibitor Mechanisms (5 papers). The work is most often cited by research in Clinical Biochemistry (500 citations), Cardiology and Cardiovascular Medicine (898 citations), Nephrology (263 citations), Cancer Research (445 citations) and Endocrinology, Diabetes and Metabolism (495 citations). Lin Lu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Ruiyan Zhang, Wei Feng Shen, Qiujing Chen, Xiao Qun Wang, Ke Yang, Ying Shen, Jian Hu, Weifeng Shen, Xiaoxiang Yan and Qichao Tu. Their work appears in journals such as Cardiovascular Diabetology, PLoS ONE, Atherosclerosis, Journal of the American Heart Association and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.